ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Circulating Epstein-Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinoma

Chen, Fo-Ping; Luo, Ying-Shan; Chen, Kai; Li, Jun-Yun; Huo, Lan-Qing; Shi, Liu; Ou-Yang, Yi; Cao, Xin-Ping*中山大学
European Journal of Cancer2021-7DOI: 10.1016/j.ejca.2021.03.052
5阅读
引用收藏
分享

摘要

Background: To investigate the value of post-induction chemotherapy (IC) cell-free Epstein-Barr virus DNA (cfEBV DNApostIC) for prognostication in locally advanced nasopharyngeal carcinoma (LA-NPC). Methods: A total of 910 histologically proven LA-NPC undergoing radical IC + concurrent chemo-radiotherapy (CCRT) or targeted radiotherapy (CTRT) or both (CTCRT) were involved. The concentration of cfEBV DNA was measured by quantitative polymerase chain reaction pre-IC (cfEBV DNApreIC) and at IC completion. CfEBV DNApostIC was classified as undetectable (0 copy/ml) and detectable (>0 copy/ml). Recursive partitioning analysis (RPA) with respect to the overall survival (OS) was applied to construct a risk stratification system incorporating cfEBV DNApostIC and critical risk factors. Results: We observed that 660 (72.5%) and 250 (27.5%) patients had cfEBV DNApostIC undetectable and detectable respectively. CfEBV DNApostIC positive was associated with a significant inferior 5-year OS (76.2% versus 85.9%), metastasis-free survival (DMFS, 71.7% versus 86.4%) and disease-free survival (DFS, 57.7% versus 80.1%) than cfEBV DNApostIC negative (P < 0.001 for all). Additionally, cfEBV DNApostIC was independently significant for OS (hazard ratio [HR] 1.90, 95% CI 1.40-2.59), DMFS (1.99, 1.45-2.71) and DFS (2.38, 1.86-3.06) in multivariate analyses (P < 0.001 for all). RPA modelling yielded three distinct risk groups:

学科与关键词

关键词
Targeted therapyConcurrent chemotherapyNeoadjuvant chemotherapyTreatment outcomeNasopharyngeal&nbspEBV DNA
相关
加载中…
  • Plasma Epstein-Barr Virus DNA Load After Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma
    Cheng-Long Huang; Zheng-Qiang Sun; Rui Guo; Xu Liu; Yan-Ping Mao; Hao Peng; Li Tian; Ai-Hua Lin; Li Li; Jian-Yong Shao; Ying Sun; Jun Ma; Ling-Long TangInternational Journal of Radiation Oncology Biology Physics, 2019, 104(2): 355-361.
  • The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma
    Liu, Li Ting; Tang, Lin Quan; Chen, Qiu Yan; Zhang, Lu; Guo, Shan Shan; Guo, Ling; Mo, Hao Yuan; Zhao, Chong; Guo, Xiang; Cao, Ka Jia; Qian, Chao Nan; Zeng, Mu Sheng; Bei, Jin Xin; Hong, Ming Huang; Shao, Jian Yong; Sun, Ying; Ma, Jun; Mai, Hai Qiang*International Journal of Radiation Oncology Biology Physics, 2015, 93(4): 862-869.被引 93
  • Integrating pre- and post-treatment Plasma Epstein-Barr Virus DNA levels for better prognostic prediction of Nasopharyngeal Carcinoma
    Li, Wanxia; Yang, Chao; Lv, Zehong; Li, Junzheng; Li, Zonghua; Yuan, Xiaofei; Wu, Shuting; Yuan, Yue; Cui, Linchong; Lu, Juan*; Chen, Jing*; Zhao, Feipeng*American Journal of Cancer Research, 2021, 12(9): 2715-2722.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Cancer
发表日期
2021-07
卷期
第 151 卷
页码
63-71
DOI
10.1016/j.ejca.2021.03.052
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81972430]

作者

  • C

    Chen, Fo-Ping (第一作者)

    sun yat sen univ

  • L

    Luo, Ying-Shan

查看全部 8 位作者收起作者
  • C

    Chen, Kai

    sun yat sen univ

  • L

    Li, Jun-Yun

    sun yat sen univ

  • H

    Huo, Lan-Qing

    sun yat sen univ

  • S

    Shi, Liu

    sun yat sen univ

  • O

    Ou-Yang, Yi

    sun yat sen univ

  • C

    Cao, Xin-Ping (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417